• DNDi-20_Logo_No-Tagline_EN_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi-20_Logo_No-Tagline_EN_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

International Conference on Innovations for the Elimination and Control of Visceral Leishmaniasis (IEC-VL)

28-30 November 2018

New Delhi, India

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

The major objective of the International Conference on Innovations for the Elimination and Control of Visceral Leishmaniasis (IEC-VL) is to bring together leading scientists from academia and industry around the world to deliberate upon new tools, new approaches, and routes to implementation.

Session

VL & PKDL– Current status from control to elimination

Date: Wednesday, 28 November 2018
Time: 11:00-12:20

Chair: Simon Croft, Professor of Parasitology, London School of Hygiene and Tropical Medicine, UK
Co-chair: Shyam Sundar, Medical field, Banaras Hindu University, Varanasi, UP, India

Elimination of kala-azar in the Indian subcontinent: Lessons from elimination of other neglected diseases
Suman Rijal, Head of Regional Office, DNDi in India
A path achieved towards kala-azar near-elimination in Bangladesh
Rajib Chowdhury, National Institute of Preventive and Social Medicine, Bangladesh
Overview of VL in India, past and present
Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India
PKDL a threat in kala-azar elimination strategy in Indian Subcontinent
Ed Zijlstra, Senior Consultant, DNDi

Epidemiology

Date: Wednesday, 28 November 2018
Time: 15:40-16:40

Chair: Nupur Roy, Additional Director, National Vector Borne Disease Control Program, India
Co-chair: Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland

The pattern of diagnosed cases in time and space during elimination and postelimination of VL in India
Graham Medley, Professor, London School of Hygiene and Tropical Medicine, UK
Determinants of disease progression and role of asymptomatic Leishmania donovani infection in transmission
Om Prakash Singh, Scientist at Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India
Leishmania donovani variant that causes cutaneous leishmaniasis in Sri Lanka
Nadira Karunaweera, Chair and Professor of Parasitology, Colombo University, Sri Lanka

Transmission

Date: Wednesday, 28 November 2018
Time: 17:20-18:20

Chair: Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India
Co-chair: Mary Cameron, Professor, London School of Hygiene and Tropical Medicine, UK

Significance of vector challenge in relation to visceral leishmaniasis control: deciphering sand fly-transmitted infections
Shaden Kamhawi, The National Institute of Allergy and Infectious Diseases, NIH, USA
The role of PKDL patients in the VL transmission in Bangladesh
Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland
When to stop Indoor Residual Spray for Kala- azar elimination
R. K. Dasgupta, Ex. Joint Director, National Vector Borne Disease Control Program, India

Drugs

Date: Thursday, 29 November 2018
Time: 8:30-9:50

Chair: Syamal Roy, Indian Institute of Chemical Biology, India
Co-chair: Dan Zilberstein, Professor of Microbiology at the Faculty of Biology, Technion, Israel Institute of Technology, Israel

Drug discovery to combat VL in India
Neena Goel, Central Drug Research Institute, India
Current and future perspectives for the development of innovative treatments for leishmaniasis
Fabiana Alves, Head of Visceral Leishmaniasis Clinical Program, DNDi, Switzerland
Therapeutic role of cholesterol in experimental visceral leishmaniasis
Syamal Roy, Indian Institute of Chemical Biology, India
PK/PD as a tool for the development and optimization of new therapies for VL
Thomas Dorlo, The Netherlands Cancer Institute, Amsterdam, Netherlands, and DNDi Consultant

Diagnostics

Date: Thursday, 29 November 2018
Time: 10:10-11:10

Chair: Suman Rijal, Head of Regional Office, DNDi in India
Co-chair: Greg Matlashewski, Interim Chair and Professor, McGill University, Canada

Post kala-azar dermal leishmaniasis (PKDL): challenges in diagnosis and treatment
Poonam Salotra, Deputy Director, National Institute of Pathology, India
Diagnosis and management of VL-HIV coinfection within the elimination framework
Sakib Burza, Medical Advisor Asia, Médecins Sans Frontières, India
Unmet diagnostic needs in leishmaniasis
Isra Cruz, Senior Scientific Officer, FIND, Switzerland

Panel Discussion

Innovations in communications and advocacy needed to sustain the elimination of VL

Date: Thursday, 29 November 2018
Time: 11:10-12:00

Chairs:

  • P.K. Sen, Director, National Vector Borne Disease Control Program, India
  • N.K. Ganguly, Former DG, Indian Council of Medical Research, India
Speakers:

  • Amresh Kumar, Team Leader/Senior Medical Officer, PATH, New Delhi, India
  • M.P. Sharma, Additional Director cum SPO, Bihar
  • Mary Cameron, Professor, London School of Hygiene and Tropical Medicine, UK
  • Amandeep Singh, Director, Global Health Strategies, India
  • Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India
  • Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland

Key outcomes, position paper on research needs and opportunities to sustain VL elimination

Date: Thursday, 29 November 2018
Time: 16:40-18:00

Chairs:

  • Piero Olliaro, Centre for Tropical Diseases and Global Health Nuffield Department of Medicine, University of Oxford, UK
  • N.K. Ganguly, Former DG, Indian Council of Medical Research, India
  • Simon Croft, Professor of Parasitology, London School of Hygiene and Tropical Medicine, UK
Speakers:

  • R. K. Das Gupta, Ex. Joint Director, National Vector Borne Disease Control Program, India
  • Hira Nakhasi, FDA, USA
  • Sakib Burza, Medical Advisor Asia, Médecins Sans Frontières, India
  • Saurabh Jain, Technical officer for vector borne and neglected tropical diseases, WHO, Switzerland
  • Suman Rijal, Head of Regional Office, DNDi in India
  • William Starbuck, Senior Program Officer, Visceral Leishmaniasis, Bill & Melinda Gates Foundation, India

More information:

  • Event website
  • Full programme

Other events

Loading...
13-14 March 2023

Putrajaya, Malaysia

Tropical Infectious Diseases Conference 2023

6 February 2023, 5 PM Madrid

Madrid, Spain and online

La Salud Global y las Enfermedades Tropicales Desatendidas en su día mundial

30 January 2023, 5-8 PM Hamburg

Hamburg, Germany

World NTD Day 2023: Snack & Talk about NTDs

29 January 2023

Referral Hospital, Baniapur, Saran, Bihar

Honouring frontline heroes of NTDs

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo